No evidence for genetic association or linkage of the cathepsin D (CTSD) exon 2 polymorphism and Alzheimer disease
- 16 January 2001
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 49 (1) , 114-116
- https://doi.org/10.1002/1531-8249(200101)49:1<114::aid-ana18>3.0.co;2-m
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- A genetic variation of cathepsin D is a major risk factor for Alzheimer's diseaseAnnals of Neurology, 2000
- Cathepsin D gene exon 2 polymorphism and sporadic Alzheimer's diseaseNeuroscience Letters, 1999
- Genetic polymorphism of cathepsin D is strongly associated with the risk for developing sporadic Alzheimer's diseaseNeuroscience Letters, 1999
- Increased Neuronal Endocytosis and Protease Delivery to Early Endosomes in Sporadic Alzheimer’s Disease: Neuropathologic Evidence for a Mechanism of Increased β-AmyloidogenesisJournal of Neuroscience, 1997
- Cathepsin D displays in vitro β-secretase-like specificityBrain Research, 1997
- ApoE-4 and Age at Onset of Alzheimer's DiseaseNeurology, 1997
- Degradation of Alzheimerʼs β-amyloid protein by human cathepsin DNeuroReport, 1996
- Clinical and pathological correlates of apolipoprotein E ε4 in Alzheimer's diseaseAnnals of Neurology, 1996
- Missense polymorphism (C/T224) in the human cathepsin D pro-fragment determined by polymerase chain reaction—Single strand conformational polymorphism analysis and possible consequences in cancer cellsEuropean Journal Of Cancer, 1994
- Reliability and Validity of NINCDS-ADRDA Criteria for Alzheimer's DiseaseArchives of Neurology, 1994